… (25), including 125 invasive papillary thyroid cancer patients … In our study, including 91
papillary thyroid cancer patients … for differentiated thyroid cancers with a worse prognosis (ie, …

… rate of the ETE of papillary thyroid cancer was lower when … of the mortality in the papillary
thyroid cancer patients was due to … , 7% of the patients still died of thyroid cancer. The ratio of …

… We describe the current best clinical staging systems and the common somatic mutations
in thyroid cancer. The BRAF mutation is the most common mutation in papillary thyroid cancer …

… In papillary thyroid cancer (PTC), the adverse prognostic impact of extrathyroidal extension
(… “extensive” with multiple structures involved (ext‐ETE), influences prognosis in T4a PTC. …

… Until recently, patients with minute thyroid cancers have routinely received surgical …
evaluate the prognostic factors of patients who underwent surgery for PMC, and to formulate …

… Our results demonstrate excellent prognosis in multicentric PTMC patients. No patients with
tumor diameter < 0.5 cm had recurrence or persistent … papillary thyroid cancer prognosis …

… The assessment of prognostic factors in papillary thyroid cancer is relevant at a time of
controversy about the place of surgery in treating the tumour6,’. There is little in the literature on …

… thyroid cancers including follicular cancers. Recent molecular analysis showed that PTC is
caused by the activation of the mitogen activated protein kinase pathway. In young patients, …

… thyroid carcinoma (HR = 1.48; 95 % CI 1.24–1.77, p < 0.001; … as independent prognostic
factors for papillary thyroid cancer … as prognostic biomarkers for recurrence in papillary thyroid …

Background Surgery is the most important treatment modality for papillary thyroid cancer (PTC).
However, the relationship between surgeon volume and long-term oncological …